Abatacept in biologic-naïve patients and TNF inadequate responders: clinical data in focus

Author： Sherrer Yvonne  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.24, Iss.8, 2008-08, pp. : 2283-2294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of infliximab with adalimumab in 827 biologic‐naïve patients with Crohn's disease: a population‐based Danish cohort study

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 5, 2018-03 ,pp. : 596-604

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease – a SONIC post hoc analysis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 8, 2015-04 ,pp. : 734-746

John Wiley & Sons Inc

Access to resources Recommend Favorite

Generalizability of Patients With Rheumatoid Arthritis in Biologic Agent Clinical Trials

By  

ARTHRITIS CARE AND RESEARCH, Vol. 68, Iss. 10, 2016-10 ,pp. : 1478-1488

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment‐naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II)

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 7, 2015-10 ,pp. : 829-844

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Influence of Clinical and Biological Factors on Transfusion-Associated Non-ABO Antigen Alloimmunization: Responders, Hyper-Responders, and Non-Responders

By  

Transfusion Medicine and Hemotherapy, Vol. 41, Iss. 6, 2014-11 ,pp. : 420-429

Karger

Access to resources Recommend Favorite